SCHEMBL24110490

SCHEMBL24110490

CC(C(=O)n1ccc2cc(F)ccc21)N(C)C

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.43
HTR2C P28335 4/20 0.43
TFPI2 P48307 1/20 0.43
HTR7 P34969 1/20 0.40
KCNH2 Q12809 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
FABP4 P15090 1/20 0.38
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SIGMAR1 Q99720 1/20 0.35
PPARG P37231 1/20 0.35
NPY5R Q15761 1/20 0.35
GRM4 Q14833 1/20 0.34
NOTUM Q6P988 1/20 0.34
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24110329 1.00 HTR2A (0.43) HTR2AHTR2CTFPI2HTR7KCNH2
SCHEMBL24109788 1.00 HTR2A (0.43) HTR2AHTR2CTFPI2HTR7KCNH2
SCHEMBL24110382 0.89 HTR2C (0.43) HTR2AHTR2CTFPI2HTR7KCNH2
SCHEMBL24110376 0.89 HTR2C (0.43) HTR2AHTR2CTFPI2HTR7KCNH2
SCHEMBL24110492 0.89 HTR2C (0.43) HTR2AHTR2CTFPI2HTR7KCNH2
SCHEMBL24110358 0.86 TFPI2 (0.42) HTR2AHTR2CTFPI2HTR7KCNH2
SCHEMBL24110373 0.86 TFPI2 (0.42) HTR2AHTR2CTFPI2HTR7KCNH2
SCHEMBL24110342 0.86 TFPI2 (0.42) HTR2AHTR2CTFPI2HTR7KCNH2
SCHEMBL24109793 0.85 HTR2A (0.44) HTR2AHTR2CTFPI2HTR7KCNH2
SCHEMBL24110338 0.85 HTR2A (0.44) HTR2AHTR2CTFPI2HTR7KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116507625-A Isochromic amine nerve plasticizer and application thereof 德力克斯疗法有限公司 2023-07-28 CN disclosed
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
WO-2021252692-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. (US) 2021-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF GAP43, SLC18A2, PNMT HTR2A 10/4885HTR2C 35/4885TFPI2 3990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.